CHICAGO, IL / ACCESSWIRE / September 22, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative ...
Cosmo Bio Co. Ltd. (3386.TO) Japan 1st Quarter Ended March 31 GROUP 2026 2025 Revenue Y3.33 bln Y3.09 bln Operating Profit Y271.00 mln Y273.00 mln Pretax Profit Y264.00 mln Y293.00 mln Net Profit Y222 ...
Labware for 3D cell culture, low-bind labware, and glycan analysis kits are designed to accelerate life science innovation. S-BIO’s labware for 3D cell culture brings the reliable performance and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results